Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Mechanisms of LIFUS for Motor Cortex Plasticity
NCT04923659Phase 1Active, not recruiting
- Sponsor
- University Health Network
- Start
- May 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial, sponsored by University Health Network. Primary endpoints: Motor Evoked Potential at 2 years, Resting Motor Threshold at 2 years and 3 more. Started May 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04923659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04923659.